Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- George E. Georges, MD
Northwestern University
Study Chair - Jeffrey A. Cohen, MD
Mellen Center for MS Treatment and Research, Cleveland Clinic
Study Chair - Paolo A. Muraro, MD, PhD
Department of Medicine, Imperial College London
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford Multiple Sclerosis Center
Palo Alto, California, United States
Jeffrey Dunn, MD, FAANRecruiting - Rocky Mountain Multiple Sclerosis Center, University of Colorado School of Medicine
Aurora, Colorado, United States
John R. Corboy, MDRecruiting - Northwestern University
Evanston, Illinois, United States
Bruce Cohen, MDGeorge Georges, MDRecruiting - University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
Carolina Ionete, MD, PhDRecruiting - University of Minnesota Multiple Sclerosis Center
Minneapolis, Minnesota, United States
Active, not recruiting - Mayo Clinic
Rochester, Minnesota, United States
B. Mark Keegan, MD,FRCPCRecruiting - John L. Trotter Multiple Sclerosis Center, Washington University School of Medicine in St. Louis
St Louis, Missouri, United States
Gregory Wu, MD, PhDRecruiting - Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Siinai
New York, New York, United States
Aaron Miller, MDRecruiting - Rochester Multiple Sclerosis Center, University of Rochester
Rochester, New York, United States
Andrew D. Goodman, MDNot, yet, recruiting - Duke University Medical Center
Durham, North Carolina, United States
Active, not recruiting - University of Cincinnati (uc) Waddell Center for Multiple Sclerosis
Cincinnati, Ohio, United States
Aram Zabeti, MDRecruiting - Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic
Cleveland, Ohio, United States
Jeffrey A. Cohen, MDRecruiting - Multiple Sclerosis Center, Oregon Health & Science University
Portland, Oregon, United States
Yadav Vijayshree, MD,MCR,FANA,FAANRecruiting - Penn Comprehensive Ms Center, Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Amit Bar-Or, MD,FRCP,FAAN,FANARecruiting - University of Texas Southwestern Medical Center: Division of Multiple Sclerosis and Neuroimmunology
Dallas, Texas, United States
Benjamin Greenberg, MDRecruiting - Maxine Mesigner Multiple Sclerosis Comprehensive Care Center, Baylor College of Medicine Medical Center
Houston, Texas, United States
George J. Hutton, MDRecruiting - University of Virginia
Charlottesville, Virginia, United States
Mini Singh, MDRecruiting - Virginia Commonwealth University Multiple Sclerosis Treatment and Research Center
Richmond, Virginia, United States
Unsong Oh, MDRecruiting - Clinical Research Division, Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Leona Holmberg, MD, PhDRecruiting - Multiple Sclerosis Center at Northwest Hospital
Seattle, Washington, United States
Annette Wundes, MDRecruiting - Multiple Sclerosis Center, Swedish Neuroscience Institute
Seattle, Washington, United States
James D. Bowen, MDRecruiting - Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Ahmed Obeidat, M.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Dec 2019
- Primary completion
- 31 Oct 2026
- Completion
- 31 Oct 2029
- Last update posted
- 6 Jan 2026
- Registered enrollment
- 156
- Registry id
- NCT04047628
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.